Greenhouse Funds’s Core Laboratories CLB Stock Holding History

Greenhouse Funds’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-33,400	Closed	-$3.62M	–	38
2018 Q1	$3.62M	Buy	+33,400	New	+$3.7M	0.96%	28

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds's CLB Position: Q2 2018 in Review

Greenhouse Funds sold out of Core Laboratories (CLB) in Q2 2018, closing a stake of 33,400 shares — an estimated $3.62M sold.

Greenhouse Funds first reported a position in CLB in Q1 2018 and held it in 1 quarter. The position peaked at $3.62M in Q1 2018. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.

Greenhouse Funds reported no remaining Core Laboratories position as of Q2 2018 after selling out during the quarter.
Greenhouse Funds sold 33,400 Core Laboratories shares in Q2 2018, an estimated $3.62M.
Greenhouse Funds first reported a position in Core Laboratories in Q1 2018 and held it in 1 quarter.
Greenhouse Funds's Core Laboratories position peaked at $3.62M in Q1 2018.
374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.

Based on Greenhouse Funds's 13F filing for Q2 2018, filed 14 Aug 2018.